Scopa James Paul

10% owner at MEMORY PHARMACEUTICALS CORP · on record since Oct 18, 2006
Director at Aligos Therapeutics, Inc. · on record since Apr 27, 2021
Director at PROLIANCE INTERNATIONAL, INC. · on record since Jan 27, 2009
10% owner at PROLIANCE INTERNATIONAL, INC. · on record since Jan 27, 2009
10% owner at Pacira BioSciences, Inc. · on record since Feb 17, 2011
10% owner at Radius Health, Inc. · on record since May 19, 2011
Former 10% stockholder at Verastem, Inc. · on record since Feb 3, 2012
Former 10% Owner at Pacira BioSciences, Inc. · on record since Mar 13, 2013
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at ARATANA THERAPEUTICS, INC. · on record since Jun 26, 2013
Director at Histogen Inc. · on record since Jul 24, 2013
10% owner at Histogen Inc. · on record since Jul 24, 2013
Director at TriVascular Technologies, Inc. · on record since Apr 23, 2014
10% owner at TriVascular Technologies, Inc. · on record since Apr 15, 2014
10% owner at CHIASMA, INC · on record since Jul 21, 2015
10% owner at CHINA ORGANIC FERTILIZER, INC. · on record since Oct 20, 2015
10% owner at Syndax Pharmaceuticals Inc · on record since Mar 9, 2016
Former 10% stockholder at Radius Health, Inc. · on record since Sep 29, 2016
Director at · on record since May 6, 2019
Director at · on record since Sep 16, 2021

Insider trading activity of Scopa James Paul

Transactions on record: 118; since Jan 15, 2009

Open-market buys: 22; $6.3M

Open-market sells: 2; $399.5K

Companies traded: 8; last filing Jun 29, 2026

Figures computed from official regulatory filings — .

Companies where Scopa James Paul has traded

10 tx · $151K · Jun 29, 2026
23 tx · $666.9K · Dec 10, 2025
23 tx · $392.5K · Aug 9, 2023
12 tx · $2M · Jun 25, 2018
15 tx · $4M · Feb 4, 2016
8 tx · Jul 21, 2015
6 tx · $3.7M · Feb 17, 2011
21 tx · $266.2K · Nov 13, 2009

Track record of Scopa James Paul

Statistical track record

Free account

Open-market buys: 22

Last buy: Feb 7, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Scopa James Paul

Co-insiders of Scopa James Paul

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aligos Therapeutics, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	5,860	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-10,450	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-3,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-10,520	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	Other	-10,333	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,666	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,500	—	n/a (No price was disclosed in the filing)		SEC
Aligos Therapeutics, Inc.Listing on record	Jun 26, 2025	AwardD (derivative)	5,860	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Jun 20, 2025	AwardD (derivative)	10,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Jun 20, 2024	AwardD (derivative)	10,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Feb 28, 2024	AwardD (derivative)	8,823	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Feb 28, 2024	OtherD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Feb 9, 2024	Buy	100,000	1.35 USD	$135K	conv 46First in 12mo	SEC
Aligos Therapeutics, Inc.Listing on record	Oct 27, 2023	AwardD (derivative)	91,541	0.13 USD	$11.9K		SEC
Aligos Therapeutics, Inc.Listing on record	Oct 27, 2023	Award	183,083	0.76 USD	$139.1K		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-21,250	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	Other	-25,722	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-8,261	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-12,096	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	Other	-15,199	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-13,800	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aligos Therapeutics, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	5,860	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-10,450	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-3,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-10,520	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	Other	-10,333	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,666	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Dec 10, 2025	OtherD (derivative)	-4,500	—	n/a (No price was disclosed in the filing)		SEC
Aligos Therapeutics, Inc.Listing on record	Jun 26, 2025	AwardD (derivative)	5,860	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Jun 20, 2025	AwardD (derivative)	10,450	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Jun 20, 2024	AwardD (derivative)	10,520	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Feb 28, 2024	AwardD (derivative)	8,823	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aligos Therapeutics, Inc.Listing on record	Feb 28, 2024	OtherD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adverum Biotechnologies, Inc.Listing unverified	Feb 9, 2024	Buy	100,000	1.35 USD	$135K	conv 46First in 12mo	SEC
Aligos Therapeutics, Inc.Listing on record	Oct 27, 2023	AwardD (derivative)	91,541	0.13 USD	$11.9K		SEC
Aligos Therapeutics, Inc.Listing on record	Oct 27, 2023	Award	183,083	0.76 USD	$139.1K		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-21,250	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	Other	-25,722	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-8,261	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-12,096	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	Other	-15,199	—	n/a (No price was disclosed in the filing)		SEC
DICE Therapeutics, Inc.Listing unverified	Aug 9, 2023	OtherD (derivative)	-13,800	—	n/a (No price was disclosed in the filing)		SEC